Positron Corporation has become an SEC reporting company, filing a Form 10 registration statement with the SEC to enhance financial transparency and corporate governance. The move positions Positron for broader institutional visibility and growth as it advances plans to uplist to a senior exchange. With accelerating demand for PET-CT imaging in cardiology and oncology, Positron’s exclusive North American partnership with Neusoft Medical Systems and expanding product portfolio are setting the stage for significant market share capture. The Company’s SEC reporting status will provide confidence to investors, customers, and partners as it continues to bring molecular imaging solutions to practices and hospitals.

Read more at GlobeNewswire: Positron Corporation Announces Its Transition to a